These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19195436)

  • 1. [Role of tenofovir in HIV and hepatitis C virus coinfection].
    Tuma P; Vispo E; Barreiro P; Soriano V
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():31-7. PubMed ID: 19195436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current role of tenofovir in clinical medicine].
    Ribera Pascuet E; Curran A
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():45-54. PubMed ID: 19338072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all analogue combinations equal?].
    Miralles Alvarez C
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():38-44. PubMed ID: 19195437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 5. Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.
    Funk EK; Shaffer A; Shivakumar B; Sneller M; Polis MA; Masur H; Heytens L; Nelson A; Kwan R; Kottilil S; Kohli A
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1190-4. PubMed ID: 23701022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conclusions. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():62-4. PubMed ID: 19195439
    [No Abstract]   [Full Text] [Related]  

  • 8. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
    Naggie S; Sulkowski MS
    Gastroenterology; 2012 May; 142(6):1324-1334.e3. PubMed ID: 22537439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tenofovir as a strategy to avoid or limit adverse effects].
    Portilla J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():19-24. PubMed ID: 19195434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin.
    Sánchez-Conde M; Gil P; Sánchez-Somolinos M; Gonzalez-Lahoz J; Soriano V
    HIV Clin Trials; 2005; 6(5):278-80. PubMed ID: 16306034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV and HCV coinfection].
    Ruiz-Sancho A; Soriano V
    Enferm Infecc Microbiol Clin; 2006 May; 24(5):335-45; quiz 346. PubMed ID: 16762261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical data I. Clinical experience with tenofovir in combination with nonnucleoside analogue transcriptase inhibitors].
    Bernardino de la Serna JI; Mora Rillo M; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():7-12. PubMed ID: 19195432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.
    Borghi V; Bisi L; Manzini L; Cossarizza A; Mussini C
    Infection; 2013 Apr; 41(2):425-9. PubMed ID: 23225268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors].
    Pulido F; Fiorante S
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():13-8. PubMed ID: 19195433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C in patients with HIV-coinfection].
    Sauleda S; Juárez A; Esteban JI
    Gastroenterol Hepatol; 2002 May; 25(5):337-41. PubMed ID: 11985811
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
    Manfredi R; Calza L
    AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir disoproxil fumarate for the treatment of HIV infection.
    Pham PA; Gallant JE
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):459-69. PubMed ID: 16863446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.